Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
E2511 in Alzheimer Disease: NCT07768592 Clinical Landscape Report 2026
16 September 2026
NCT07768592 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in Advanced gastric carcinoma: NCT07770113 Clinical Landscape Report 2026
16 September 2026
NCT07770113 clinical landscape for Advanced gastric carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesalamine in Chronic diarrhea: NCT07767370 Clinical Landscape Report 2026
16 September 2026
NCT07767370 clinical landscape for Chronic diarrhea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07777211 Clinical Landscape Report 2026
16 September 2026
NCT07777211 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
TRB-001 (Tridem Bioscience) in Parkinson Disease: NCT07777484 Clinical Landscape Report 2026
16 September 2026
NCT07777484 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesalamine in Pouchitis: NCT07773948 Clinical Landscape Report 2026
16 September 2026
NCT07773948 clinical landscape for Pouchitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Finerenone in Diabetes Mellitus, Type 2: NCT07775846 Clinical Landscape Report 2026
16 September 2026
NCT07775846 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Alpelisib in Diabetes Mellitus, Type 2: NCT07778524 Clinical Landscape Report 2026
16 September 2026
NCT07778524 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PRX-005 in Alzheimer Disease: NCT07780383 Clinical Landscape Report 2026
16 September 2026
NCT07780383 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Finerenone in Acute Kidney Injury: NCT07775482 Clinical Landscape Report 2026
16 September 2026
NCT07775482 clinical landscape for Acute Kidney Injury: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin Propanediol/Metformin Hydrochloride in Diabetes Mellitus, Type 2: NCT07778719 Clinical Landscape Report 2026
16 September 2026
NCT07778719 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RO-7568282 in Parkinson Disease: NCT07781644 Clinical Landscape Report 2026
16 September 2026
NCT07781644 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.